Medication info
Tamitrasemi Tablets

Tamitrasemi Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Samik Pharmaceuticals Co., Ltd.
Appearance
Light yellow, rectangular film-coated tablets
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 200805632 · Notified 2008.05.20 · Insurance code 644003090

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this drug for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued use of this drug is appropriate. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and hemofiltration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day.

Ingredients

Manufacturer
Samik Pharmaceuticals Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible period. Do not use this drug for longer than necessary. If long-term use is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued use of this drug is appropriate. Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and hemofiltration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day.

Precautions

This medication may put strain on the liver, so individuals who consume more than a certain amount of alcohol daily must consult a doctor or pharmacist before use. Severe allergic reactions may occur on the skin while taking this medication. If a rash or hypersensitivity reaction occurs, stop taking it immediately and consult healthcare professionals. The ingredients in this medication can trigger seizures; therefore, patients with a history of seizures or those at high risk of seizures should use this medication cautiously, as the risk may increase when taken with certain medications. Although rare, life-threatening allergic reactions may occur while taking this medication. If any unusual symptoms arise, seek immediate medical attention. In patients with severe respiratory diseases, this medication may cause difficulty in breathing; therefore, it should only be used in an environment where healthcare professionals can monitor the patient. Taking this medication with alcohol or certain central nervous system depressants may lead to severe drowsiness, respiratory depression, or coma, so concurrent use should be avoided unless absolutely necessary, in which case it should be done with extreme caution. Patients with head injuries or brain diseases should be cautious when taking this medication, as respiratory depression could worsen their condition. This medication can lead to psychological and physical dependence, so long-term use should be carefully monitored for signs of dependence. Patients with impaired liver function must consult a doctor before using this medication and must be careful not to exceed the daily dose. Patients with specific genetic metabolic characteristics may have faster metabolism of the active ingredient in this medication, which can increase the risk of serious respiratory depression; alternative medications or dose adjustments may be necessary in such cases. Children under 12 years old or pediatric patients under 18 years old after certain surgeries should not use this medication; administration in adolescents aged 12 to 18 should also be avoided if there are special risk factors. This medication may induce sleep apnea or hypoxia, so it is important to continuously monitor for any symptoms and consider dose adjustments or discontinuation if they appear or worsen. During treatment with this medication, hyponatremia, a rare electrolyte disorder, may occur, so elderly patients or those with risk factors should have their condition checked through blood tests. Patients with hypersensitivity to any components of this medication, those with toxicity from certain central nervous system drugs, severe respiratory depression, head injuries, or those taking MAO inhibitors should not take this medication. Women who are pregnant or breastfeeding must consult a doctor before using this medication, particularly while breastfeeding, as it may pass into breast milk and pose risks to the baby. This medication can cause drowsiness or dizziness; therefore, it is advisable to avoid dangerous tasks such as driving or operating machinery after ingestion. In cases of overdose, severe respiratory depression, seizures, and liver damage may occur, so it is crucial to adhere strictly to the recommended doses and to seek emergency care if an overdose occurs. Care should be taken not to combine this medication with other analgesics or medications containing acetaminophen, as potential drug interactions are a concern; patients should inform healthcare professionals about any other medications they are taking.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, fatal respiratory suppression, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flush, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraines, drowsiness, sensory loss, tremors, paresthesia, attention disorders, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased serum creatinine, anaphylaxis reaction, impact on emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue glutamic acidosis, high anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, fainting, congestive heart failure, vertigo, confusion, heightened tension, migraine exacerbation, involuntary muscle contractions, exercise-induced respiratory distress, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, arrhythmia, exacerbation of hypertension, aortic stenosis, hemorrhage, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, constipation, vomiting, dyspepsia, abdominal pain, dry mouth, diarrhea, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, tinnitus, confusion, multiple organ failure, intentional overdose, chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a well-closed container that allows minimal air exchange and at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Light yellow, rectangular film-coated tablets

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.